{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0472-1783",
      "marketing_end_date": "20270228",
      "generic_name": "Diclofenac Sodium",
      "labeler_name": "Actavis Pharma, Inc.",
      "brand_name": "Diclofenac Sodium",
      "active_ingredients": [
        {
          "name": "DICLOFENAC SODIUM",
          "strength": "30 mg/g"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0472-1783-10",
          "description": "1 TUBE in 1 CARTON (0472-1783-10)  / 100 g in 1 TUBE",
          "marketing_start_date": "20160519",
          "marketing_end_date": "20270228",
          "sample": false
        }
      ],
      "openfda": {
        "manufacturer_name": [
          "Actavis Pharma, Inc."
        ],
        "rxcui": [
          "855642"
        ],
        "spl_set_id": [
          "74169b2d-ac56-4757-86c4-cdcfcd5f4eb5"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "QTG126297Q"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "GEL",
      "spl_id": "6b4784a2-31ca-485a-9bff-6c322c0cb902",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "TOPICAL"
      ],
      "marketing_start_date": "20160519",
      "product_id": "0472-1783_6b4784a2-31ca-485a-9bff-6c322c0cb902",
      "application_number": "ANDA206493",
      "brand_name_base": "Diclofenac Sodium",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Prostaglandin Production [PE]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]"
      ]
    }
  ]
}